To evaluate the changes in types of medications prescribed for pain before and after withdrawal of certain selective cyclooxygenase 2 (COX-2) inhibitors in 2004 and to determine whether there was an association with fall events in elderly adults with a diagnosis of osteoarthritis (OA). DESIGN: A nested case-control design using electronic medical records compiled between 2001 and 2009. SETTING: Electronic medical records for care provided in an integrated health system in rural Pennsylvania over a 9-year period (2001-09), the midpoint of which rofecoxib and valdecoxib were pulled from the market. PARTICIPANTS: Thirteen thousand three hundred fiftyfour individuals aged 65 to 89 with a diagnosis of OA. MEASUREMENTS: The incidence of falls and fractures was examined in relation to analgesics prescribed: narcotics, COX-2 inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs). The comparison sample of individuals who did not fall was matched 3:1 with those who fell according to age, sex, and comorbidity. RESULTS: Narcotic analgesic prescriptions were associated with a significantly greater risk of falls and fractures. The likelihood of experiencing a fall/fracture was higher in participants prescribed narcotic analgesics than those prescribed a COX-2 inhibitor (odds ratio (OR) = 3.3, 95% confidence interval (CI) = 2.5-4.3) or NSAID (OR = 4.1, 95% CI = 3.7-4.5). CONCLUSION: Use of narcotic analgesics is associated with risk of falls and fractures in elderly adults with OA, an observation that suggests that the current guidelines for the treatment of pain, which include first-line prescription of narcotics, should be reevaluated. J Am Geriatr Soc 61:335-340, 2013.
F
alls are a common occurrence in elderly adults, with 30% of people aged 65 and older and 50% of those aged 80 and older falling at least once each year. 1 The consequences of a fall (severe injuries, loss of function and independence) can be devastating to elderly adults. Of individuals aged 65 and older with trauma related to a fall, 32% experienced a severe injury, and the fall was seven times as likely to be the cause of death as for those younger than 65. 2 Half of all older adults hospitalized for hip fracture never regain their former level of function. 3 Falls also have a significant psychological effect, because fear of falling can lead to reduction in physical function and social interactions. 4 In 2000, the total direct cost of all fall injuries for people aged 65 and older exceeded $19 billion. 5 This has led to a national mandate to lower the incidence of falls in elderly individuals. 6 Although studies have examined medications and falls in inpatient and nursing home settings, 7, 8 only a few recent studies have examined the influence of prescription analgesics on falls in elderly populations outside of the hospital or nursing home setting, and these studies measured falls by individual recall. One study reported that significantly more fall-coded healthcare encounters were documented for nonhospitalized individuals taking medications that affect the sensorium, such as narcotic analgesics. 9 Nevertheless, all of the community-based studies showed a significant association between falls and narcotics. [10] [11] [12] Cyclooxygenase 2 (COX-2)-selective nonsteroidal antiinflammatory drugs (NSAIDs) were initially hailed as a significant advance for the treatment of pain when first introduced in 1999, having excellent analgesic effect without the gastrointestinal toxicity of nonselective NSAIDs or the central nervous system toxicity of opiates, 13, 14 but after 5 years of use, certain COX-2-selective agents were associated with a significant risk of cardiovascular disease, leading to withdrawal of some of these agents at the end of 2004. 15 In response, the American Heart Association pain management recommendations identified the "short-term use of narcotic analgesics as the first step in pain relief management." 16 The revised American Geriatrics Society guidelines for the management of persistent pain in older adults recommends, "nonselective NSAIDs and COX-2 selective inhibitors be considered rarely, with caution, in highly selected individuals and all individuals with moderate to severe pain, pain-related functional impairment or diminished quality of life due to pain be considered for opioid therapy." 17 Although these recommendations addressed concerns about cardiovascular complications related to these medications, it has been reported that individuals taking opiate analgesics experience more cardiovascular complications and fractures than comparable individuals taking NSAIDs or COX-2-selective agents. 18, 19 The current study examined relationships between analgesics prescribed for symptomatic management of pain in osteoarthritis (OA) and the incidence of falls and fractures in elderly adults with a diagnosis of OA. The focus was on changes after these COX-2 inhibitors were taken off the market. This understanding is timely, given the need to limit common adverse events and maximize potential health benefits in elderly adults. The hypothesis was that, since 2004, more narcotic analgesics would be used for pain management. The related hypothesis, that the incidence of falls and fractures would increase after 2004, was also examined.
METHODS
A cohort of 13,354 participants was used to examine the relationship between prescriptions for pain management and falls in community-dwelling elderly adults. The period of interest was the 9 year period from 2001 to 2009, the midpoint being the dates (September 2004-April 2005) that rofecoxib and valdecoxib were pulled from the market. The institutional review board of Geisinger Health System (GHS), a vertically integrated system that provides primary and multispecialty health services to more than 2.6 million people in central and northeast Pennsylvania, approved the study.
Study Participants
Geisinger Health System has used an electronic medical records (EMR) system in all of its 41 ambulatory care clinics for more than 10 years, facilitating research with community-based populations and development of innovative care models. Patient information is routinely integrated into a common database that is shared across inpatient and outpatient settings. These data include personal characteristics (e.g., age, sex, height, weight); lifestyle characteristics (e.g., smoking, alcohol); clinical measures (e.g., blood pressure, pulmonary function, bone mineral density); digital imaging (magnetic resonance imaging, computed tomography, X-ray) results; International Classification of Diseases, Ninth Revision (ICD-9) diagnoses; laboratory results; treatments; and prescription orders. GHS also provides a remarkably stable population across 31 counties (except in two counties, the outmigration rate is <1% per year), which offers unique opportunities for longitudinal research. The Geisinger EMR system captures individuals' problem lists and prescriptions and the details surrounding the occurrence of adverse events.
Records of all elderly adults with a diagnosis of OA during from 2001 to 2009 were accessed from the GHS data warehouse. Established for research purposes, the warehouse provides a shadow copy of the actual EMR and is housed on a separate server. An honest broker (a non-research team member) accesses data, which is de-identified to comply with internal policy and the Health Insurance Portability and Accountability Act Privacy Rule. For this study, the data set consisted of 13,354 individuals for whom OA was listed on their EMR problem list. Eligibility criteria included being aged 65 to 89 ( ! 90 is considered a potentially identifiable characteristic) and having received care from a GHS physician (in an acute or ambulatory setting) between January 2001 and December 2009. During this 9 year period, 3,830 falls and fractures were documented for 2,462 GHS patients.
Measurements and Covariates
Diagnoses of falls and fractures were identified according to ICD-9 codes (Table 1) , which included codes for common falls in older individuals in nonhospital settings (e.g., from steps, furniture) and common fractures (e.g., hips, extremities). Falls that occurred in a hospital setting were excluded, as were spontaneous and spinal fractures. Conservative rules were established to address inconsistencies noted in the data accessed from the EMR. Because one fall could be coded multiple times in different settings (e.g., emergency department, orthopedic follow-up visit) and coded as a fall and as a resulting fracture, a combined fall-fracture variable was developed. Fall and fracture events were counted only once in a discrete 6 month period so that follow-up care was not considered a new event.
Analgesic prescriptions were categorized into the following hierarchy of three mutually exclusive analgesic treatment groups: narcotics (opiate with or without other pain medication, including a COX-2 inhibitor) COX-2 (COX-2-selective agents with or without other pain medications but not narcotics), or NSAID group (NSAID with or without other pain medication, excluding narcotics and COX-2 inhibitors) ( Table 2 ). Many pain medications did not fit into these categories. For this preliminary study, the decision was made to exclude other medications, because the primary purpose was to compare narcotics with NSA-IDS and COX-2 inhibitors.
Covariates included the obvious participant characteristics associated with fall risk: age, sex, and comorbidity. Charlson Index scores (range 0-9) were calculated to indicate the overall influence of concurrent conditions on health, with higher scores reflecting more comorbidities. 20 Although the Charlson Index is not a comprehensive risk tool, it is a valid measure of the prognostic effect of comorbid disease that allowed some potential confounders to be addressed in this population.
Statistics
Falls were identified as a time-specific event to examine a set of potential influences in the time before the fall; a 6 month period was set as a "clean period" such that separate falls were defined as occurring at least 6 months apart. Variations in sample characteristics, analgesic medications, and incidence of falls were examined for each of the 9 years of study data and in the two study periods: 2001 to 2004 and 2005 to 2009 (before and after the withdrawal of COX-2 inhibitors). The characteristics of participants who experienced multiple falls were examined by looking backward over the whole time period.
Analysis was undertaken to determine whether the older age and greater comorbidity level of participants receiving narcotic analgesic prescriptions accounted for the greater number and percentage of participants experiencing falls and fractures. Incidence density sampling was used to obtain unbiased results. Using exact matching methods, controls (no fall or fracture) were matched 3:1 to cases according to sex, age (AE1 year) and Charlson Index score (AE1) calculated specific to the time the fall occurred. For each participant experiencing a fall, controls were randomly selected at the time a fall event occurred, excluding other cases with falls. Under this scheme, a participant was capable of being selected multiple times as a control.
A conditional logistic regression model was used to compare the effect of the different pain medications on the risk of falls for the two study periods, using SAS version 9.2 (SAS Institute, Inc., Cary, NC) to conduct an analysis for a matched study. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were obtained. The use of conditional logistic regression accounts for correlations induced by the matching of cases and controls and the possible selection of one case multiple times.
RESULTS
Study data consisted of 13,354 records identified for individuals aged 65-89 with a diagnosis of OA. Of this set, 87% received care in both the COX-2 and post-COX-2 time periods. Before the nested case-control analysis, participants with OA who experienced falls or fractures were older and had more comorbidities than participants who did not (Table 3 ). In the later period, participants experiencing falls and fractures were also significantly more likely to be male, although this difference was small (Table 3) . Fewer participant records were available for the first 2 years of data because of delayed record entry into the EMR. The smaller sample size affected the totals reported for prescriptions and falls and fractures in each medication group for the 2001 to 2004 study period. The uneven sample size was addressed in the subsequent analysis with a nested casecontrol design, which may have led to an apparent increase in the variability in medication use and the fall rate.
The percentage of participants who received narcotic prescriptions increased steadily over the period of study (Figure 1) . In 2001, only 61 (1.6%) of the 3,731 participants were prescribed narcotic analgesics. This peaked in (Figure 1) . Fall rates for all participants tripled over the study period (Figure 2) . A greater percentage of participants experienced falls and fractures in the post-COX-2 study period (2005-2009) than in the earlier time period. The group of participants treated with narcotic analgesics accounted for the greatest number of falls and fractures. Although there appeared to be marked fluctuations and an overall increase in the percentage of participants experiencing falls and fractures who were prescribed COX-2-selective analgesics, the number of participants in the COX-2 group was small, leading to variability in the rate of falls and fractures ( Table 4) .
As noted above, in the total unmatched cohort of participants studied, falls and fractures were significantly more common in older adults with higher Charlson scores (Table 3) ; 2,462 participants experienced 3,830 fall or fracture events during the study period. Participants experiencing falls and fractures were matched 1:3 with OA controls (no falls and fractures) according to age, sex, and Charlson Index score at the time of the fall or fracture and calendar time, a sample totaling 7,214 unique participants (Table 2) . Most participants experienced a single fall or fracture (n = 1,709, 69.4%); some fell twice (n = 443, 18.0%), and 310 (12.6%) fell three or more times. Participants who received narcotic analgesics were significantly more likely to experience a fall or fracture in both study periods. Overall, the OR was 3.3 for falls and fractures for participants who received a narcotic analgesic compared with participants who received a COX-2 inhibitor, and 4.1 when compared with participants who received a NSAID (Table 5) .
DISCUSSION
As the percentage of elderly adults with OA who were prescribed opiate analgesics increased, there was a corresponding increase in the percentage of elderly adults who experienced a fall or fracture. Moreover, individuals who were prescribed narcotic analgesics accounted for most of the increase in the percentage of individuals experiencing falls and fractures after 2004. Although participants experiencing falls and fractures were older and had significantly more comorbidities, after controlling for age and comorbidities, narcotic analgesic prescriptions remained a significant risk factor, emphasizing the salience of discussing fall precautions and assessing fall risks as part of analgesic treatment.
The investigation of a disease such as OA has inherent difficulties because the severity and chronicity of pain can be difficult to judge from an objective standpoint. To address the concern that participants who were prescribed 100  95  90  85  80  75  70  65  60  55  50  45  40  35  30  25  20  15 narcotics are different from participants given COX-2 inhibitors or NSAIDS, the Charlson score was used, and participants were matched based on age and sex. Because falls are so closely associated with mortality, 2 using a risk tool such as the Charlson Index that predicts risk of death from other comorbidities provided a way of ensuring that matched participants' mortality risks were similar.
Rofecoxib removed from the market
Study limitations included lack of data regarding the duration of analgesic use in relation to a fall or fracture event or the use of other medications associated with falls or known to affect the sensorium. Likewise, no data were collected to confirm that analgesic prescriptions were filled or whether other prescriptions were received from physicians in other health systems. Certain medications such as tramadol, which has some narcotic properties, and propoxyphene hydrochloride, a narcotic that has been removed from the market, were not included in the analysis. Baseline pain levels and effectiveness of pain management in participants with falls was not explored. The conservative coding rules probably undercounted falls, because some elderly adults have recurrent falls, and many do not seek medical attention for falls. No data were examined regarding the fall risks surrounding gait, vision, living situation, and social supports. Likewise, the data did not capture the possible influence of disability level, neurological disorders (e.g., Parkinson's disease), obesity, and concurrent drugs (e.g., antidepressants), nor were the data reviewed for fractures unrelated to other trauma, such as an auto crash. As with all case-control studies, this study was susceptible to confounding. Attempts to control were made by matching based on Charlson Index score, age, and sex. There are other risks that would need to be controlled for in a more-detailed, thorough study.
Over the course of this decade, physician prescribing habits underwent a significant change for elderly adults with OA. At the beginning of the decade, an increasing number of elderly adults was prescribed selective COX-2 inhibitors for the treatment of OA. As the number of reports of cardiovascular toxicity of COX-2 inhibitors and NSAIDs increased in 2003 and 2004, there was a concomitant decline in use of these agents, and a growing percentage of individuals was prescribed narcotic analgesics. By the end of the decade, nearly 40% of this population was being treated with narcotic analgesics. Guidelines promulgated in 2007 by the American Heart Association validated and encouraged this prescribing trend, although the morbidity and mortality of falls and fractures associated with narcotic analgesic use was not considered in developing these practice guidelines. A recent epidemiological study suggested that use of narcotic analgesics is associated with a significantly greater risk of cardiovascular morbidity and mortality than NSAIDs and selective COX-2 inhibitors. 21 It is unlikely that the American Heart Association or the American Geriatrics Society would have promulgated guidelines recommending use of narcotic analgesics, even short-term use as first-line therapy for elderly adults with OA if information about the risks had been known at the time. Nonetheless, some consideration should be given to revising these guidelines with new, emerging evidence associated with narcotics. The association between prescriptions for narcotic analgesics and falls and fractures in this population may reflect the known central nervous system effects of narcotic analgesics, which age often compounds. 21, 22 Younger individuals are at less risk of injury from falls and fractures than elderly adults because of greater muscle mass, better balance, and less osteoporosis. Nonetheless, prescription of even short-term narcotics for relief of OA pain is likely to lead to other forms of morbidity and mortality.
The results of this preliminary study, that narcotic use increased alongside documented fall events and fracture injuries, suggests an unintended consequence of adoption of a change in treatment practices without due consideration of potential side effects. This deleterious change in prescribing habits, even though effected to combat a potentially serious side effect of a new and expensive form of drug therapy, selective COX-2 inhibitor-associated cardiovascular toxicity, 14 led to a significant increase in morbidity in this elderly population of individuals with OA. The growing national movement to develop and enforce practice guidelines to improve quality of care is likely to reduce prescription of unnecessary or dangerous procedures and drugs and reduce complications. Nonetheless, the current guidelines for the treatment of pain, which include first-line prescription of narcotics, should be reevaluated.
